Oral Dosage Form New Animal Drugs;Trilostane

• Date: November 01, 2009
• Source: www.fda.gov

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the supplemental approval of a new animal drug application (NADA) filed by Dechra, Ltd. The supplemental NADA provides for the addition of a 10- milligram capsule size of trilostane, used in dogs for treatment of hyperadrenocorticism.

Effective Date: This rule is effective June 26,2009.

Click here to download the file